Amgen (AMGN) PT Raised to $252 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $480.99 +0.52%
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Join SI Premium – FREE
Oppenheimer analyst Jay Olson raised the price target on Amgen (NASDAQ: AMGN) to $252.00 (from $250.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Amgen (AMGN) PT Raised to $400 at Bernstein SocGen Group
- Procore Technologies, Inc (PCOR) PT Raised to $86 at BMO Capital on 'Impressive Execution'
- Pinnacle West Capital (PNW) PT Raised to $108 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
